• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Rosetta Genomics, Ltd. (ROSG)

    -NasdaqCM
    2.35 Up 0.03(1.29%) 3:56PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 405   201   103  
    Cost of Revenue709  258  324  
    Gross Profit (304) (57) (221)
    Operating Expenses
    Research Development1,744  1,247  3,386  
    Selling General and Administrative11,299  6,963  5,170  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (13,347) (8,267) (8,777)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes(13,170)(10,696)(7,393)
    Interest Expense -   -   -  
    Income Before Tax(13,170)(10,696)(7,393)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(13,170)(10,696)(7,393)
    Non-recurring Events
    Discontinued Operations273  239  (1,437)
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (12,897) (10,457) (8,830)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (12,897) (10,457) (8,830)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.